EMV — EMvision Medical Devices Cashflow Statement
0.000.00%
Last trade - 00:00- AU$167.61m
- AU$156.75m
- AU$11.56m
- 15
- 20
- 73
- 30
Annual cashflow statement for EMvision Medical Devices, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2020 June 30th | 2021 June 30th | 2022 June 30th | R2023 June 30th | 2024 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Changes in Working Capital | 0.037 | 1.33 | 2.01 | 2.62 | 2.93 |
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -3.26 | -4.49 | -3.78 | 0.834 | -5.99 |
| Capital Expenditures | — | -0.127 | -0.191 | -0.187 | -0.302 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Cash from Investing Activities | — | -0.127 | -0.191 | -0.187 | -0.302 |
| Financing Cash Flow Items | — | — | — | -0.075 | -0.002 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 4.28 | 8.9 | 1.08 | 2.45 | 15 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 1.03 | 4.28 | -2.89 | 3.1 | 8.71 |